COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies

May 13 2020 | 00:21:18

/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 13, 2022 00:24:33
Episode Cover

Double Sequential External Defibrillation for Refractory Ventricular Fibrillation

More than 350,000 cardiac arrests occur each year in North America.  Approximately 100,000 of these arrests are due to shockable rhythms.  Unfortunately, many patients...

Listen

Episode 0

September 11, 2018 00:24:03
Episode Cover

Bicarbonate for Severe Acidosis?

Many critically ill patients are acidotic.  Often, bicarbonate is administered to severely acidotic patients, but does it really improve outcomes?  The BICAR-ICU was just...

Listen

Episode 0

February 14, 2017 00:29:35
Episode Cover

Surviving Sepsis Campaign 2016 Update

The SSC recently published its new recommendations for the management of sepsis and septic shock.  We discuss the key changes and controversies that you...

Listen